ERBB2 and breast carcinoma: In accordance with the ASCO CAP 2018 HER2 Testing for Breast Cancer Guidelines, cases with immunohistochemistry (IHC) scores of 0 or 1 + were not classified as HER2-positive, and fluorescence in situ hybridization (FISH) testing for these scores was not considered.